Home » Topics » Regulatory

Regulatory
RSS

Generic clindamycin approved by FDA

July 28, 1997

Known heart failure drug studied for AML

July 28, 1997

FDA clears potent pain reliever without opioid side effects from Wyeth-Ayerst

July 24, 1997

Teva's generic antihypertensive combination tentatively approved

July 23, 1997

U.K. approves Astra's treatment for ulcerative colitis

July 23, 1997

Prograf to be submitted in Japan for atopic dermatitis

July 22, 1997

TAP receives FDA approval to market new formulation of Lupron Depot

July 21, 1997

Rogaine Extra Strength for Men recommended for approval as OTC

July 21, 1997

FDA clears new indication and new labeling for Zoloft

July 18, 1997

Ganciclovir implant effective in treating CMV retinitis

July 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...